Hugh was Chairman and CEO of Monsanto for 15 years until the £53Bn sale to Bayer in 2018. During this time, Hugh successfully led the strategic transformation from a chemical company to a global seed and technology pioneer through strong R&D investment and over 70 strategic M&A transactions. He has been recognised globally as a leader in business and Life Sciences, renowned for his emphasis on innovation.